Thousands of women with early but aggressive breast cancer could benefit from a drug that has been approved by UK regulators, say experts.
Pertuzumab (Perjeta) fights HER2-positive breast cancer and its new licence means it can be used before surgery to shrink and control tumours.
Click to read more.
http://www.bbc.co.uk/news/health-34380192
